News
11h
Barchart on MSNShould You Buy the Post-Earnings Dip in Lululemon Stock?Lululemon (LULU) shares are down some 20% on Friday after the athletic apparel retailer reported slightly ...
11h
RetailWire on MSNLululemon Delivers Solid Q1 2025 Earnings, Yet Stock Price Plunges Over Tariffs and Other ConcernsIts most recent fiscal report card — its Q1 2025 earnings report, delivered late June 5 — reinforces the idea that Lululemon ...
Revenue: Total revenue was $1.3 million for Q1 2025, up from $1.2 million in Q4 2024. Both figures reflect approximately a 50 ...
Should you buy PL stock now, or is it too late? Planet posted several firsts that caught investors’ attention. Recurring ...
Dexterra retains a buy rating after strong revenue growth, improved margins, and successful integration of CMI acquisition.
DocuSign's Q1'26 earnings beat estimates, showcasing 30% FCF margins and raised outlook. Find out why I am upgrading DOCU ...
Ultragenyx Pharmaceutical, a Marin County maker of treatments for rare conditions, expects up to 20% sales growth this year.
CFO Siddharth Thacker stated that gross margins (GAAP) decreased to 31.5% in Q1 FY2025, down from 37.9% a year earlier and 37 ...
Live Updates Live Coverage Has Ended More Lululemon Figures 4:34 pm by Here’s the numbers from Lululemon: Q1 Revenues: $2.37 ...
EngageLab Contract Value: 63 million RMB newly signed in Q1 2025, bringing the total cumulative contract value to over 110 ...
First-quarter revenues were up 2 per cent for the Calvin Klein and Tommy Hilfiger owner. But PVH warned of a tough year ahead ...
Given MDB’s recent stock increase and inherent volatility, you may be questioning whether it remains a sound investment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results